Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FMmeds vs QuickMD

FMmeds
Graded #257

Lower grade

vs+1.7000000000000028
QuickMD
Graded #232

Higher grade

The verdict

QuickMD takes it — 64.9/100 to 63.2/100, but only just.

QuickMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. QuickMD is a high-volume telemedicine platform (over 1 million visits) offering same-day online weight-management care. FMmeds is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFMmeds +1
46
45
Dose & formulationQuickMD +4
72
76
Clinical oversightQuickMD +16
70
86
Labs & monitoringFMmeds +1
53
52
FulfillmentFMmeds +26
97
71
Contract termsQuickMD +14
47
61
FMmeds · left barQuickMD · right bar

The numbers

MetricFMmedsQuickMD
WeighScore63.2/10064.9/100
GradeCC
Scorecard rank#257#232
Semaglutide$225/mo (all doses, compounded)$279/mo (compounded)
Tirzepatide$265/mo (all doses, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
FMmeds

Graded #257 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
QuickMD

Graded #232 · C

Strengths

  • Compounded semaglutide around $279/mo plus brand-name GLP-1 options
  • Same-day, 365-day-a-year online visits
  • Large established platform with over 1 million completed visits
  • Transparent cash-pay pricing with reimbursement summaries
  • Can prescribe Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus

Where it loses points

  • Does not accept insurance
  • Available in 45+ states, not all 50
  • Medication cost varies by pharmacy, not fully bundled
  • No named board-certified physicians listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard